Table 1 VH gene analysis of gastric MALT lymphoma cases

From: Immunoglobulin VH gene analysis in gastric MALT lymphomas

Case

Age

Sex

H. pylori infection

H. pylori eradication

API2-MALT1 fusion

Group

VH

Homology (%)

Somatic mutation

Ongoing mutation

D

JH

          

Confirmed

Unconfirmed

No

  

1

44

M

+

Responsive

−

A

VH3–11

97.9

+

 

+

 

D2–15

JH5

2

61

M

+

Responsive

−

A

VH3–23

97.3

+

 

+

 

D5–12

JH3

3

45

F

+

Responsive

−

A

VH3–23

100

−

  

+

ND

JH4

4

71

F

+

Responsive

−

A

VH3–23

96.6

+

 

+

 

D3–9

JH4

5

75

M

+

Responsive

−

A

VH3–23

96.6

+

 

+

 

D6–19

JH3

6

57

F

+

Responsive

−

A

VH3–23

95.9

+

  

+

D3–10

JH5

7

64

F

+

Responsive

−

A

VH3–23

93.9

+

 

+

 

ND

JH6

8

51

M

+

Responsive

−

A

VH3–23

93.2

+

 

+

 

D2–15

JH4

9

66

M

+

Responsive

−

A

VH3–23

89.8

+

  

+

ND

JH5

10

63

M

+

Responsive

−

A

VH3–23

85.0

+

 

+

 

D6–13

JH5

11

65

F

+

Responsive

−

A

VH3–30

99.3

−

  

+

D6–19

JH4

12

53

M

+

Responsive

−

A

VH3–30

99.3

−

 

+

 

D2–2

JH6

13

62

F

+

Responsive

−

A

VH3–30

97.9

+

 

+

 

D2–15

JH4

14

52

F

+

Responsive

−

A

VH3–30

97.3

+

 

+

 

D4–17

JH3

15

70

M

+

Responsive

−

A

VH3–30

81.6

+

 

+

 

ND

JH5

16

54

F

+

Responsive

−

A

VH3–35

94.6

+

 

+

 

D5–18

JH6

17

59

M

+

Responsive

−

A

VH3–7

95.2

+

 

+

 

ND

JH4

18

58

M

+

Responsive

−

A

VH3–7

94.6

+

+

+

 

D3–22

JH3

19

52

M

+

Responsive

−

A

VH4–34

97.2

+

 

+

 

D6–13

JH4

20

75

M

+

Responsive

−

A

VH4–34

83.3

+

  

+

D1–26

JH4

21

60

F

+

Responsive

−

A

VH4–61

96.5

+

 

+

 

D3–10

JH5

22

70

M

+

Responsive

−

A

VH4–61

94.4

+

+

+

 

D6–13

JH5

23

53

F

+

Responsive

−

A

VH4–61

86.8

+

  

+

D6–13

JH4

24

37

F

+

Resistant

−

B

VH1–69

85.7

+

 

+

 

ND

JH4

25

62

M

+

Resistant

−

B

VH3–11

95.2

+

 

+

 

D5–24

JH6

26

41

F

−

Resistant

−

B

VH3–21

97.3

+

  

+

D3–10

JH6

27

60

M

+

Resistant

−

B

VH3–30

98.6

−

 

+

 

D2–2

JH6

28

73

F

+

Resistant

−

B

VH3–33

87.8

+

 

+

 

D3–16

JH4

29

70

F

+

Resistant

−

B

VH3–7

97.3

+

+

+

 

D6–19

JH4

30

62

F

+

Resistant

−

B

VH3–7

86.4

+

 

+

 

ND

JH3

31

82

M

+

Resistant

−

B

VH4–34

97.2

+

 

+

 

D3–10

JH5

32

72

M

+

Resistant

−

B

VH4–61

97.9

+

  

+

ND

JH5

33

16

M

+

Resistant

−

B

VH4–61

95.8

+

  

+

D6–13

JH4

34

43

M

−

Resistant

+

C

VH3–11

83.0

+

 

+

 

ND

JH4

35

50

M

−

Resistant

+

C

VH3–13

97.9

+

  

+

D3–22

JH4

36

53

M

+

Resistant

+

C

VH3–21

95.2

+

  

+

D4–23

JH4

37

81

M

−

Resistant

+

C

VH3–21

89.1

+

 

+

 

ND

JH4

38

63

F

+

Resistant

+

C

VH3–23

97.9

+

 

+

 

ND

JH5

39

42

M

−

Resistant

+

C

VH3–30

97.3

+

 

+

 

D5–12

JH6

40

70

F

+

Resistant

+

C

VH3–7

97.9

+

 

+

 

ND

JH6

41

70

M

−

Resistant

+

C

VH3–9

96.6

+

  

+

D6–19

JH4

42

50

F

−

Resistant

+

C

VH4–61

99.3

−

 

+

 

D3–10

JH5

43

64

F

+

Resistant

+

C

VH4–61

97.9

+

 

+

 

D3–10

JH5

44

78

F

−

Resistant

+

C

VH4–61

97.2

+

 

+

 

ND

JH5

45

60

F

−

Resistant

+

C

VH5–51

95.9

+

 

+

 

ND

JH3

  1. Group A: responsive to eradication and negative for API2-MALT1 fusion; Group B: resistant to eradication and negative for the fusion; Group C: resistant to eradication and positive for the fusion; ND, not determined.